TOO FIT TO FRACTURE Evidence based recommendations to help reduce the risk of fractures Exercises for Healthy Bones The 2023 Clinical Practice Guideline on the Diagnosis and Management of Osteoporosis […]

LONG TERM CARE Long Term Care Video Series Osteoporosis Canada, Ontario Osteoporosis Strategy, University of Waterloo and GERAS Centre for Aging Research are excited to announce the launch of four […]

PARATHYROID HORMONE (PTH) A new class of osteoporosis treatments called bone formation agents Parathyroid hormone analogues belong to a class of osteoporosis medications which can promote bone growth. In Canada, […]

Guideline and Recommendations 2023 Clinical Practice Guideline The 2023 guideline contains 25 recommendations and 10 good practice statements with a focus on exercise, nutrition, fracture risk assessment, treatment and more […]

BISPHOSPHONATES The most common family of drugs used to treat osteoporosis Bisphosphonates are the most common family of drugs used to treat osteoporosis. They are part of the group of […]

Brookfield Chair in Fracture Prevention Funds New Fracture Liaison Service (FLS) Program in Fredericton, NB

OSTEOPOROSIS RESEARCH Research Awards Osteoporosis Canada is proud to support clinical, translational and health-outcomes research that focuses on the high fracture-risk population and more specifically, preventing fractures and their negative […]

Prepared and reviewed by members of the Scientific Advisory Council of Osteoporosis Canada Calcium is essential for the achievement and maintenance of normal bone health. The current daily requirements for […]

In 15 of the studies the mean baseline vitamin D level was over 50 nmol/l which is higher than values seen in a significant number of Canadian men and women […]